DHA:BXPHARMA (Bangladesh)  
Beximco Pharmaceuticals Ltd logo

Beximco Pharmaceuticals Ltd

BDT 170.10 (-0.58%) Sep 29
P/E:
13.24
P/B:
1.91
Market Cap:
BDT 75.88B ($ 748.73M)
Enterprise V:
BDT 87.12B ($ 859.65M)
Volume:
383.52K
Avg Vol (2M):
814.98K
Also Trade In:
Volume:
383.52K
Market Cap BDT:
75.88B
Market Cap $:
748.73M
PE Ratio:
13.24
Avg Vol (2-Month):
814.98K
Enterprise Value BDT:
87.12B
Enterprise Value $:
859.65M
PB Ratio:
1.91
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset 0.61
Debt-to-Equity 0.3
Debt-to-EBITDA 1.46
Interest Coverage 8.19
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.73
Distress
Grey
Safe
Beneish M-Score -1.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.87
9-Day RSI 38.7
14-Day RSI 45.94
6-1 Month Momentum % -7.73
12-1 Month Momentum % -30.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.43
Quick Ratio 0.58
Cash Ratio 0.05
Days Inventory 182.46
Days Sales Outstanding 34.08
Days Payable 42.3

Financials (Next Earnings Date:2022-11-02 Est.)

DHA:BXPHARMA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil BDT) 33,659.547
EPS (TTM) (BDT) 12.85
Beta 0
Volatility % 20.82
14-Day RSI 45.94
14-Day ATR (BDT) 6.637977
20-Day SMA (BDT) 178.09
12-1 Month Momentum % -30.62
52-Week Range (BDT) 140.7 - 255.4
Shares Outstanding (Mil) 446.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Beximco Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

Beximco Pharmaceuticals Ltd Analysis

Share your research